Straits Times Index
3,343.35 +11.65 (+0.35%) S&P 500
5,482.87 +4.97 (+0.09%) Dow
39,164.06 +36.26 (+0.09%) Nasdaq
17,858.68 +53.53 (+0.30%) Bitcoin USD
61,481.27 +682.37 (+1.12%) CMC Crypto 200
1,283.98 +17.83 (+1.41%)
XENE Jul 2024 42.500 put
| Previous close | 5.50 |
| Open | 5.65 |
| Bid | 4.70 |
| Ask | 7.50 |
| Strike | 42.50 |
| Expiry date | 2024-07-19 |
| Day's range | 5.65 - 5.65 |
| Contract range | N/A |
| Volume | |
| Open interest | 4 |
Insider MonkeyIs Xenon Pharmaceuticals Inc. (XENE) One of the Best Healthcare Stocks Under $50?
We recently compiled a list of the 10 Best Healthcare Stocks to Buy Under $50. In this article, we are going to take a look at where Xenon Pharmaceuticals Inc. (NASDAQ:XENE) stands against the other healthcare stocks under $50. If interested, you can also read our recent article on the 10 Best Healthcare Stocks To […]
GlobeNewswireXenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
VANCOUVER, British Columbia, June 05, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present at the Goldman Sachs 45th Annual Global Healthcare Conference taking place June 10-13, 2024 in Miami, FL. Fireside Chat Presentation Details: Date:Wednesday, June 12, 2024Time:4:00 pm Eastern TimeWebcast:Register herePresenters:Ian Mortimer, President and Chief Executive OfficerChris Von Seggern, C
Simply Wall St.Shareholders Will Probably Not Have Any Issues With Xenon Pharmaceuticals Inc.'s (NASDAQ:XENE) CEO Compensation
Key Insights Xenon Pharmaceuticals to hold its Annual General Meeting on 4th of June Total pay for CEO Ian Mortimer...
